Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 121 - 140 out of 500 displayed.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Kura Oncology Provides Update on Phase 2 Trial of Tipifarnib in HRAS Mutant Head and Neck Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Kura Oncology, Inc.

Sales of Olainfarm in January Exceed 9 Million Euros

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Olainfarm

Daré Bioscience, Inc. Announces Effective License and Collaboration Agreement for Topical Sildenafil for Female Sexual Arousal Disorder

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Daré Bioscience, Inc.

JAMA Oncology Publication Demonstrates EndoPredict® (EPClin) Significantly Outperforms Oncotype DX® Recurrence Score in Early-Stage Breast Cancer

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Myriad Genetics, Inc.

PetVivo Holdings, Inc. Adds Special Revenue Consultant Approaching Commercial Production

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018

Catalyst Biosciences Announces Closing of Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Catalyst Biosciences

GUERBET : 2017 revenue at constant exchange rates: €812.4 million; +4.7%

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Global Blood Therapeutics Inc.

FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Agios Pharmaceuticals, Inc.

LHC Group Announces Fourth Quarter and Year-End 2017 Earnings Release and Conference Call Dates

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  LHC Group, Inc.

Inovalon to Participate at 2018 RBC Capital Markets Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Inovalon

Burgess Source Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third Party Privacy, Security and Compliance

Read more ››
By: Nasdaq / GlobenewsWire - 15 Feb 2018
Related companies:  Burgess

Glassbeam Announces Artificial Intelligence Application for Healthcare Provider Market

SANTA CLARA, Calif., Feb. 15, 2018 /PRNewswire/ -- Glassbeam, Inc., the premier machine data analytics company, announced today that it has successfully built Artificial Intelligence (AI) applications powered by Machine Learning (ML) models for predicting part failures in expensive imaging modalities,... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2018

Practice Velocity Expands Leadership Team by Adding Vice President of Marketing and Vice President of Business Development

MACHESNEY PARK, Ill., Feb. 15, 2018 /PRNewswire/ -- Urgent care software solutions company Practice Velocity is growing, adding two new leaders to its core leadership team of urgent care experts. Practice Velocity is pleased to announce that Jaimie Kowalski has joined the company as vice president... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2018

Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration

WARREN, N.J., Feb. 15, 2018 /PRNewswire/ -- Celularity has been created through the contribution and acquisition of extensive intellectual property, clinical-stage assets, basic and clinical research, and product development expertise including:

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2018
Related companies:  Celgene Corporation | United Therapeutics Corporation | Sorrento Therapeutics, Inc.

Xtelligent Media, LLC Becomes a HIMSS Approved Education Partner

DANVERS, Mass., Feb. 15, 2018 /PRNewswire/ -- As a result of meeting HIMSS's rigorous standards for quality health IT and healthcare education, Xtelligent Media has been named as a HIMSS Approved Education Partner (AEP).

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2018
Related companies:  HIMSS

FDA expands treatment window for use of clot retrieval devices in certain stroke patients

SILVER SPRING, Md., Feb. 15, 2018 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today cleared the use of the Trevo clot retrieval device to treat certain stroke patients up to 24 hours after symptom onset, expanding the device's indication to a broader group of patients. This... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2018
Related companies:  U.S. Food and Drug Administration

Global Orphan Drug Access and Pricing in Emerging Markets 2018: Gulf Region Presents the Most Lucrative Opportunity, with Well-Funded Niches in Other Regions

DUBLIN, Feb. 15, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2018

The Guardant360® Assay Receives Expedited Access Pathway Designation for Breakthrough Devices from FDA

REDWOOD CITY, Calif., Feb. 15, 2018 /PRNewswire/ -- The Guardant360® assay, the leading comprehensive liquid biopsy, received an Expedited Access Pathway (EAP) designation from the United States Food and Drug Administration, Guardant... Read more ››

By: PR Newswire Association LLC. - 15 Feb 2018
Related companies:  Guardant Health, Inc

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2018-2024 - Favorable Market Parameters & Commercialization Challenges

DUBLIN, Feb. 15, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2018

AbbVie Increases Dividend and Announces New Stock Repurchase Program

NORTH CHICAGO, Ill., Feb. 15, 2018 /PRNewswire/ -- The board of directors of AbbVie (NYSE: ABBV) increased the company's quarterly cash dividend by 35 percent from $0.71 per share to $0.96 per share and authorized a new $10 billion stock repurchase program.

Read more ››
By: PR Newswire Association LLC. - 15 Feb 2018
Related companies:  AbbVie Inc.
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑